Publications

2019

Ouseph MM, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, et al. TKI-resistant -rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Lung Cancer (Auckl). 2019;10:81-86.
Oriakhi M, Ortiz-Diaz E, Olibrice M, Ahluwalia M, Chadburn A, Shostak E. Endobronchial Obstruction by a Solitary Extramedullary Plasmacytoma With Light-chain Amyloidosis. J Bronchology Interv Pulmonol. 2019;26(2):e24-e26.
Kabraji S, Sole X, Huang Y, Bango C, Sgroi D, Loda M, et al. AKT1 quiescent cancer cells in ductal carcinoma in situ of the breast. NPJ Breast Cancer. 2019;5:10.
Sfeir MM, Hayden JA, Fauntleroy KA, Mazur C, Johnson JK, Simner PJ, et al. EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing . J Clin Microbiol. 2019;57(5).
Ahmed A, Crowson N, Magro CM. A comprehensive assessment of cutaneous Rosai-Dorfman disease. Ann Diagn Pathol. 2019;40:166-173.
Karras P, Riveiro-Falkenbach E, Cañón E, Tejedo C, Calvo TG, Martínez-Herranz R, et al. p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors. Cancer Cell. 2019;35(1):46-63.e10.
Adams EJ, Karthaus WR, Hoover E, Liu D, Gruet A, Zhang Z, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571(7765):408-412.
Velu PD, Perl AE, Luger SM, Bagg A, Morrissette JJ. Longitudinal targeted next-generation sequencing in a patient with acute myeloid leukaemia. Br J Haematol. 2019;186(6):801.
Donaldson K, Buchanich JM, Grigson PS, Deneke E, Donaldson K, Vrana KE, et al. Abstracts of Presentations at the Association of Clinical Scientists 139 Meeting Hershey, PA, May 15-18, 2019. Ann Clin Lab Sci. 2019;49(3):403-416.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700